Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
about
Antibody-drug conjugates as novel anti-cancer chemotherapeuticsAFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy.A semi high-throughput method for screening small bispecific antibodies with high cytotoxicityT cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.Affinity maturation of humanized anti-epidermal growth factor receptor antibody using a modified phage-based open sandwich selection method.Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity.
P2860
Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rearranging the domain order o ...... esistance and pharmacokinetics
@ast
Rearranging the domain order o ...... esistance and pharmacokinetics
@en
type
label
Rearranging the domain order o ...... esistance and pharmacokinetics
@ast
Rearranging the domain order o ...... esistance and pharmacokinetics
@en
prefLabel
Rearranging the domain order o ...... esistance and pharmacokinetics
@ast
Rearranging the domain order o ...... esistance and pharmacokinetics
@en
P2093
P2860
P356
P1476
Rearranging the domain order o ...... esistance and pharmacokinetics
@en
P2093
Hiroki Hayashi
Hiromi Ogata
Ippei Shimomura
Izumi Kumagai
Kyoko Arai
Masayoshi Onitsuka
Michiaki Unno
Mitsuo Umetsu
P2860
P304
P356
10.4161/MABS.29445
P577
2014-10-30T00:00:00Z